Precision Optics (NASDAQ:POCI) & DexCom (NASDAQ:DXCM) Critical Analysis

Precision Optics (NASDAQ:POCI) and DexCom (NASDAQ:DXCM) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, profitability and earnings.

Earnings and Valuation

This table compares Precision Optics and DexCom”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precision Optics	$31.53 million	1.77	-$3.63 million	($0.46)	-11.04
DexCom	$4.66 billion	6.39	$836.30 million	$2.55	31.34

DexCom has higher revenue and earnings than Precision Optics. Precision Optics is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

13.7% of Precision Optics shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 12.7% of Precision Optics shares are owned by insiders. Comparatively, 0.3% of DexCom shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Precision Optics and DexCom’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Precision Optics	-11.51%	-23.92%	-13.05%
DexCom	19.42%	37.77%	15.98%

Analyst Recommendations

This is a summary of recent recommendations and price targets for Precision Optics and DexCom, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precision Optics	1	0	0	0	1.00
DexCom	0	2	24	2	3.00

DexCom has a consensus target price of $95.50, suggesting a potential upside of 19.49%. Given DexCom’s stronger consensus rating and higher possible upside, analysts clearly believe DexCom is more favorable than Precision Optics.

Risk & Volatility

Precision Optics has a beta of 0.23, indicating that its stock price is 77% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.45, indicating that its stock price is 45% more volatile than the S&P 500.

Summary

DexCom beats Precision Optics on 14 of the 15 factors compared between the two stocks.

About Precision Optics

Precision Optics Corporation, Inc. is a medical technology company that develops and manufactures advanced optical systems and components for minimally invasive medical procedures. The company works primarily with medical device manufacturers, providing specialized imaging technologies designed to support visualization during surgery and other clinical applications. Its product portfolio includes rigid and flexible endoscopes, three-dimensional endoscopic systems, disposable and reusable visualization devices, surgical cameras, and custom optical assemblies.

About DexCom

DexCom, Inc. develops and markets continuous glucose monitoring (CGM) systems for people with diabetes. Its wearable sensors measure glucose levels throughout the day and send readings to compatible receivers or mobile devices, helping users monitor glucose trends and support treatment decisions. The company’s products include its Dexcom G6 and G7 CGM systems, along with software and connected services for users and caregivers. DexCom also offers Stelo, an over-the-counter glucose biosensor designed for adults who do not use insulin.